Pharmacodynamics of fluconazole, itraconazole, and amphotericin B against Candida albicans☆

This publication has 11 references indexed in Scilit:

• Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans
  Antimicrobial Agents and Chemotherapy, 1997
• Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections
  Clinical Infectious Diseases, 1997
• Detection of amphotericin B-resistant Candida isolates in a broth-based system
  Antimicrobial Agents and Chemotherapy, 1995
• A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia
  New England Journal of Medicine, 1994
• Risk Factors for Fungal Infection in Patients with Malignant Hematologic Disorders: Implications for Empirical Therapy and Prophylaxis
  Clinical Infectious Diseases, 1994
• Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
  The Journal of Infectious Diseases, 1993
• Candidemia in a Tertiary Care Hospital: Epidemiology, Risk Factors, and Predictors of Mortality
  Clinical Infectious Diseases, 1992
• Yeast in blood cultures evaluation of factors influencing outcome
  Diagnostic Microbiology and Infectious Disease, 1992
• Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989
  The American Journal of Medicine, 1991
• In-vitro activity of SCH39304 in comparison with amphotericin B and flaconazole
  Journal of Antimicrobial Chemotherapy, 1990